Browsing Tag
Guardant Health
16 posts
Guardant Health launches Hereditary Cancer Test to expand precision oncology offerings
Guardant Health unveils its new hereditary cancer test to detect inherited genetic risks across 12+ cancer types. Learn how this aids precision treatment plans.
PTC Therapeutics, TG Therapeutics, and Zimmer Biomet among top U.S. stock losers
See which U.S. stocks fell the most on May 5, 2025, and why—an in-depth look at the market’s biggest losers amid trade tensions and sector-specific headwinds.
Inocras launches MRDVision with ppm-level sensitivity, setting new standard in cancer recurrence detection
Inocras launches MRDVision with ppm-level ctDNA sensitivity, setting a new MRD testing standard—discover how it could transform cancer monitoring today.
Guardant Health’s Shield blood test gains ADLT status, strengthening Medicare coverage for colorectal cancer screening
Guardant Health, Inc. has received Advanced Diagnostic Laboratory Test (ADLT) status from the Centers for Medicare & Medicaid…
FDA gives green light to Guardant Health’s Shield blood test: A game-changer in colorectal cancer screening and Medicare coverage
In a landmark decision, the U.S. Food and Drug Administration (FDA) has approved Guardant Health, Inc.’s Shield blood…
FDA approves Guardant360 CDx assay as companion diagnostic for Menarini’s ORSERDU for metastatic breast cancer
Guardant Health, an oncology company, has secured the approval of the US Food and Drug Administration (FDA) for…